Introduction: Wuhan Rejuvenate Bio-technology Co., Ltd (Rejuvenate) was founded in 2010, headquartered in Wuhan, located in Wuhan East Lake Hi-Tech Zone National Bio-industry Base Biomedical Park. Founded by returnees who studied and worked in Europe and the United States, the company is mainly engaged in the research and development and production of new protein-based drugs, and is a global pioneer in the research and development of calcium oxalate kidney stone drugs. The company was listed on China's New Third Board in 2015, stock code 832036. Wuhan Rehabilitation Bio-technology Co., Ltd. is mainly engaged in the research and development and production of new protein-based drugs, and is a global pioneer in the research and development of calcium oxalate kidney stone drugs.
Legal representative: Qingshan Li
Establishment: 2010-08-24
Registered capital: 72.8 million yuan
Industrial and Commercial Registration No.: 420000000205756
Enterprise type: limited liability company (non-listed, natural person investment or holding)
Wuhan Rehabilitation Bio-technology Co. p>Address: 3/F (1) Factory Building, Building 4, Wuhan Optics Valley International Biomedical Accelerator Phase 3.1, No. 388 Gaoxin Road 2, Donghu New Technology Development Zone, Wuhan City